Anlon Healthcare profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
Returns
12.4%
7.8%
17.3%
10.7%
Margins
27.6%
26.8%
24.7%
16.9%
16.6%
−46.2%
Additional
31.6%
12.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AHCL₹24.47

Anlon Healthcare Limited

· Pharma & Health
₹ CrorePeersANUHPHRWANBURYBAJAJHCAREZIMLABTHEMISMEDLINCOLNSIGACHIVALIANTLABMcap ₹130 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Returns
Return on Common Equity12.38
Return on Assets7.78
Return on Capital Employed17.26
Return on Invested Capital10.70
Margins
EBITDA Margin27.63
Operating Margin26.75
Pretax Margin24.72
Net Income Margin16.92
Net Income to Common Margin16.58
FCF Margin-46.20
Additional
Effective Tax Rate31.57
Sustainable Growth Rate12.38
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.